Ipilimumab-associated bilateral optic neuropathy
- PMID: 25647225
- DOI: 10.1097/WNO.0000000000000217
Ipilimumab-associated bilateral optic neuropathy
Abstract
Ipilimumab is a novel monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) receptor that has been shown to improve survival in metastatic melanoma. Previous case reports have documented its association with drug-induced uveitis. We report a patient who developed bilateral optic neuropathy with disc edema while taking this medication.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
